| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/30/2010 | EP2202245A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| 06/30/2010 | EP2202243A2 Antigen binding domains from fish |
| 06/30/2010 | EP2202242A1 Inactivation resistant factor VIII related applications |
| 06/30/2010 | EP2202241A2 Therapeutic compounds and methods for modulating V3, a versican isoform |
| 06/30/2010 | EP2201959A2 Use of IL-12 and IL-12 antagonists for the manufacture of a pharmaceutical composition for the treatment of autoimmune diseases |
| 06/30/2010 | EP1390535B1 Combinatorial libraries of monomer domains |
| 06/30/2010 | CN1896261B Production of rice-starch and rice-protein polypeptide powder by composite enzyme method |
| 06/30/2010 | CN101760493A Method for producing cyclosporine A by fermentation |
| 06/30/2010 | CN101760492A Method for extracting algae glycoproteins |
| 06/30/2010 | CN101760471A Aspergillus expression vector and application thereof |
| 06/30/2010 | CN101760470A Method for preparing human growth hormone recombinant |
| 06/30/2010 | CN101759806A Cytoplasm leader peptide (CTD)-containing human epidermal growth factor fusion protein (CTD-hEGF) prepared by using hydroxylamine cutting method and application thereof |
| 06/30/2010 | CN101759775A Leech active small peptide and preparation method and application thereof |
| 06/30/2010 | CN101759768A Purification method for producing gamma-interferon |
| 06/29/2010 | US7745699 Herbicide metabolizing proteins; ferredoxins; methylation, dehydrogenation; kits |
| 06/29/2010 | US7745693 Inhibitors of plant peptide deformylase for use as broad-spectrum herbicides and methods for identifying the same |
| 06/29/2010 | US7745604 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell |
| 06/29/2010 | US7745601 Nucleic acids encoding T2R, a novel family of taste receptors |
| 06/29/2010 | US7745599 Hexose oxidase-encoding DNAs and methods of use thereof |
| 06/29/2010 | US7745592 Expression vector comprising cumate-inducible regulatory switch for use in gene transfer; TATA elements; bioassays; genomics and gene therapy; trangenic animals; host cells |
| 06/29/2010 | US7745586 antiidiotypic, chimeric, humanized, monoclonal or polyclonal antibodies or faragments that specifically binds polypeptides having synthetase enzyme activity |
| 06/29/2010 | US7745585 humanized, chimeric, genetic engineered, monoclonal or polyclonal antibody, or fragment, useful in the therapy of cancer, fibrosis and chronic obstructive pulmonary disease |
| 06/29/2010 | US7745584 Antibodies to sulfated carbohydrates |
| 06/29/2010 | US7745569 polypeptide comprising amino acid sequences that interact with amyloid plaques containing amyloid beta (A beta ) peptide, useful as carrier molecules to deliver drugs and diagnostic reagents to amyloid plaques |
| 06/29/2010 | US7745465 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 06/29/2010 | US7745406 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders |
| 06/29/2010 | US7745230 Estrogen receptors and methods of use |
| 06/29/2010 | US7745212 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 06/29/2010 | US7745193 recombinant nucleotide sequence which codes upon expression for at least a part of a bifunctional hybrid active-site serine beta -lactamase protein |
| 06/29/2010 | US7745190 Endoribonuclease |
| 06/29/2010 | US7745189 encodes a cotA polypeptide having serine/threonine kinase activity ; modulation of genes associated with hyphal growth in filamentous fungi |
| 06/29/2010 | US7745188 Heat resistant and error-prone polymerase for use as mutational tool in genetic analysis |
| 06/29/2010 | US7745186 Ribulose, 1,5-bisphosphate carboxylase/oxygenase polypeptides and related polynucleotides |
| 06/29/2010 | US7745184 Using transgenic escherichia expressing galactose-proton symporter and reduced glycerolaldehyde 3-phosphate dehydrogenase as bioreactor for 1,3-propanediol production |
| 06/29/2010 | US7745179 Lentiviral producer cell; such as mounse transthyretin (mTTR) promoter (antibody); recombinant lentiviruses and transfer vectors for transgene delivery and gene therapy; blood coagulation factor IX; antihemopohilic factor |
| 06/29/2010 | US7745176 using an E. coli expression system for the large scale production of IL-21 to a level of greater than 1 g/L in fed batch fermentation |
| 06/29/2010 | US7745174 co-expressing two heterotypes of Hepatocyte Growth Factor (HGF) comprising transforming or transfecting to a cell a DNA construct; for prevention and treatment of ischemic and liver disorders |
| 06/29/2010 | US7745172 Via L-aspartic acid- alpha,beta-diester and L-phenylalanine using enzyme that has ability to selectively link L-phenylalanine to alpha -ester site of L-aspartic acid- alpha,beta-diester through peptide bond/nucleophilic attack; easy, high yield and inexpensively without going through a complex synthesis |
| 06/29/2010 | US7745171 Cell-free protein synthesis method using insect cell extract solution |
| 06/29/2010 | US7744907 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 06/29/2010 | US7744903 Epitopes confirmed to be recognized by T-cells derived from herpetic lesions or uterine cervix; vaccination; host cells |
| 06/29/2010 | US7744900 Expression cassettes provided comprising a promoter operably linked to a nucleic acid which when transcribed in vivo, forms double stranded RNA that induces the production of interferon(alpha, beta, or gamma) either directly or indirectly, which in turnmay upregulate MHC Class I and/ or II |
| 06/29/2010 | US7744896 therapeutic vaccine anti-HIV, anti-AIDS and against tumors and syndromes associated with HIV infection |
| 06/29/2010 | US7744886 Methods for interfering with rank signaling |
| 06/29/2010 | US7744884 Using toll-like receptor 4 specific immunoglobulin as therapeutic tool in treatment and prevention of inflammatory bowel, atherosclerotic and arthritic disorders |
| 06/29/2010 | US7744881 for cancer treatment by inducing apoptosis; monoclonal antibodies; drug conjugated with polyoxyethylene glycol or enzyme or radioisotope, fluorescent compound or chemiluminescent compound; genetic engineering; biodrugs; anticarcinogenic agents |
| 06/29/2010 | US7744879 Blood-brain barrier targeting antibodies |
| 06/29/2010 | US7744878 Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof |
| 06/29/2010 | US7744862 Propagating and isolating cell growth factors from prokaryotic systems using ion exchange and reverse phase chromatography; bioreactor and heterologous gene expression |
| 06/29/2010 | CA2636421C A method of platelet and whole blood storage |
| 06/29/2010 | CA2398467C Antibody for detecting chlamydia pneumoniae |
| 06/29/2010 | CA2390082C Novel hcv non-structural polypeptide |
| 06/29/2010 | CA2370477C Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 06/29/2010 | CA2312188C Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 06/29/2010 | CA2252372C Pathogenic escherichia coli associated protein |
| 06/29/2010 | CA2236700C Immunity against pasteurella haemolytica leukotoxin |
| 06/29/2010 | CA2163976C Methods and compositions for inhibiting cd14 mediated cell activation |
| 06/29/2010 | CA2134030C Soluble interferon .alpha.-receptor, its preparation and use |
| 06/24/2010 | WO2010036951A3 Methods and compositions for producing carbon-based products of interest in micro-organisms |
| 06/24/2010 | WO2009151948A3 Spatio-temporal control of protein interactions using phytochromes |
| 06/24/2010 | US20100162439 Pesticidal genes from brevibacillus and methods for their use |
| 06/24/2010 | US20100162418 Recombinant protein s composition |
| 06/24/2010 | US20100162417 Methods for increasing the diversity of monoclonal antibodies produced against an antigen |
| 06/24/2010 | US20100162415 Transgenic mice expressing humanized vegf |
| 06/24/2010 | US20100160618 Expanding the eukaryotic genetic code |
| 06/24/2010 | US20100160611 Human skeletal muscle-specific ubiquitin-conjugating enzyme |
| 06/24/2010 | US20100160235 Fgf homologs compositions and uses thereof |
| 06/24/2010 | US20100160227 Signaling peptides |
| 06/24/2010 | US20100160225 Lefty, lefty derivatives and uses thereof |
| 06/24/2010 | US20100160217 Acetylycholine gated ion channel chaperons and methods of using the same |
| 06/24/2010 | US20100160212 Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses |
| 06/24/2010 | US20100160174 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 06/24/2010 | US20100159592 Emulsion compositions |
| 06/24/2010 | US20100159514 System for production of ethanol and co-products with fractionation of feedstock and solvent washing of fermentation product |
| 06/24/2010 | US20100159513 Genes that increase peptide production |
| 06/24/2010 | US20100159512 Method for the preparation of recombinant human thrombin and fibrinogen |
| 06/24/2010 | US20100159511 Production of recombinant selenoprotein mutants with enhanced catalytic activity |
| 06/24/2010 | US20100159510 Transgenic plants expressing civps or intein modified proteins and related method |
| 06/24/2010 | US20100159489 Promoter |
| 06/24/2010 | US20100159467 Method for replicating the hepatitis c virus |
| 06/24/2010 | US20100159465 Screening of Abundantly Secreted Proteins and Their Use as Fusion Partners for the Production of Recombinant Proteins |
| 06/24/2010 | US20100159453 Genes involved in intestinal inflammatory diseases and use thereof |
| 06/24/2010 | US20100158975 Extracellular matrix compositions |
| 06/24/2010 | US20100158955 Phl p 5a derivatives having reduced allergeneity and retained t-cell reactivity |
| 06/24/2010 | US20100158935 Mutant forms of streptolysin o |
| 06/24/2010 | US20100158931 Novel immunotherapy against several tumors including neuronal and brain tumors |
| 06/24/2010 | US20100158926 Antibodies to erbb2 |
| 06/24/2010 | US20100158911 Compositions and Methods of Treating Disease with FGFR Fusion Proteins |
| 06/24/2010 | US20100158906 Use of recombinant monoclonal antibody with specific binding activity for cell surface phosphorylated glycoprotein in diagnosis and treatment of immune, cell proliferative and inflammatory disorders |
| 06/24/2010 | US20100158902 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 06/24/2010 | US20100158891 Human Coagulation Factor VII Variants |
| 06/24/2010 | US20100158886 Triple acting antimicrobials that are refractory to resistance development |
| 06/24/2010 | US20100158879 Expression cassette and vector for transient or stable expression of exogenous molecules |
| 06/24/2010 | US20100158803 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies |
| 06/24/2010 | DE102008063900A1 Verfahren zur fermentativen Herstellung von heterologen Proteinen mittels Escherichia coli Process for the fermentative production of heterologous proteins by Escherichia coli |
| 06/23/2010 | EP2199390A1 Anti-epha2 antibody |
| 06/23/2010 | EP2199299A2 Antisense modulation of survivin expression |
| 06/23/2010 | EP2198870A1 Activator for blood coagulation factor vii promoter and utilization of the same |
| 06/23/2010 | EP2198039A2 Microorganism engineered to produce isopropanol |
| 06/23/2010 | EP2198037A1 Chemo-enzymatic peptide synthesis via c-terminal ester interconversion |